# A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

> **NCT04897022** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Malignant Pleural Mesothelioma

## Interventions

- **DRUG:** Pembrolizumab
- **RADIATION:** IMPRINT

## Key facts

- **NCT ID:** NCT04897022
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897022, "A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04897022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*